Alfa Gargle, the povidone-iodine brand of one of the leading pharmaceutical companies, Pascual Laboratories, Inc. (PascualLab), proudly announces its partnership with Smile Train Philippines, to support less fortunate children with cleft lips and palates.
As corporate social responsibility is a cornerstone of PascualLab’s core values, the company remains committed to supporting underserved community members through various initiatives and in partnership with various organizations and institutions. PascualLab is proud to announce a collaborative effort with Smile Train Philippines, united by a shared belief: that the path to a happy and healthy life for every child begins with a smile. Through this partnership, more children with cleft will have the opportunity to tread this journey. As part of its commitment to enhancing oral health, PascualLab seeks to help in the post-operation care of these children through Alfa Gargle. For every purchase of Alfa Gargle, a portion of the sale goes to Smile Train Philippines.
Alfa Gargle, which contains 1% Povidone-Iodine and has been clinically proven to eradicate disease-causing bacteria, based on representative bacteria tested, provides an affordable option for the treatment of individuals with sore throat, tonsillitis, and mouth sores, to help them go on with their daily activities and remain productive.
Beyond consumers, the brand also reaches out to dentists who need post-op antiseptic solutions.
With Smile Train, Alfa Gargle hopes to assist less fortunate children with cleft lips and palates, help transform their lives, build their confidence, and give them more reasons to smile. For more information about Alfa Gargle and its partnership with Smile Train Philippines, you may visit www.facebook.com/AlfaGargle.
Alfa Gargle is available in all leading drugstores nationwide and PascualLab’s official online stores:
Lazada: https://www.lazada.com.ph/shop/pascuallab
Shopee: https://shopee.ph/pascuallabstore
TikTok Shop: https://www.tiktok.com/@officialpascuallab
IF SYMPTOMS PERSIST, CONSULT YOUR DOCTOR.
